Literature DB >> 24939469

The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond.

Peter Crome1, Antonio Cherubini, Joaquim Oristrell.   

Abstract

There is general agreement that the growth of the numbers of older people throughout the world has significant implications for both health and social care and for the prevention and treatment of disease and disability. The optimum use of pharmaceuticals and possibly nutraceuticals is, and will to a greater extent, therefore be of crucial importance. A snapshot of the current status of older people in relation to the issues discussed in this review is provided in an informative report published by Age UK.

Entities:  

Keywords:  cardiovascular disease; clinical trial; drug treatment; older people; patients view

Mesh：

Year:  2014        PMID： 24939469     DOI： 10.1586/17512433.2014.922864

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN： 1751-2433            Impact factor:   5.045


  9 in total

Review 1.  Radiotherapy issues in elderly breast cancer patients.

Authors:  Ian Kunkler
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

Review 2.  Nuances in the Management of Older People With Multiple Myeloma.

Authors:  Charlotte Pawlyn; Francesca Gay; Alessandra Larocca; Vivek Roy; Sikander Ailawadhi
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

Review 3.  The value of pragmatic and observational studies in health care and public health.

Authors:  Maxwell S Barnish; Steve Turner
Journal:  Pragmat Obs Res       Date:  2017-05-12

Review 4.  Evaluating glucose-lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial.

Authors:  Alan J Sinclair; Simon R Heller; Richard E Pratley; Ran Duan; Robert J Heine; Andreas Festa; Jacek Kiljański
Journal:  Diabetes Obes Metab       Date:  2020-03-11       Impact factor: 6.577

5.  Engaging older patients in cardiovascular research: observational analysis of the ICON-1 study.

Authors:  Hannah Sinclair; Jonathan A Batty; Weiliang Qiu; Vijay Kunadian
Journal:  Open Heart       Date:  2016-08-03

6.  Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process.

Authors:  Miles D Witham; Eleanor Anderson; Camille Carroll; Paul M Dark; Kim Down; Alistair S Hall; Joanna Knee; Rebecca H Maier; Gail A Mountain; Gary Nestor; Laurie Oliva; Sarah R Prowse; Amanda Tortice; James Wason; Lynn Rochester
Journal:  Trials       Date:  2020-08-01       Impact factor: 2.279

7.  Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial.

Authors:  Fleur O'Hare; Simone Spark; Zachary Flanagan; Stephane Heritier; Andrea Curtis; Sophia Zoungas
Journal:  Contemp Clin Trials Commun       Date:  2018-06-12

8.  Overcoming barriers to the involvement of deafblind people in conversations about research: recommendations from individuals with Usher syndrome.

Authors:  Andrew Skilton; Emma Boswell; Kevin Prince; Priya Francome-Wood; Mariya Moosajee
Journal:  Res Involv Engagem       Date:  2018-10-26

Review 9.  Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients.

Authors:  Benjamin Brenner; Roopen Arya; Jan Beyer-Westendorf; James Douketis; Russell Hull; Ismail Elalamy; Davide Imberti; Zhenguo Zhai
Journal:  Thromb J       Date:  2019-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.